Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Industry

Image: Under the agreement, Natera will evaluate ctDNA from clinical trial samples collected in CytoDyn’s CLOVER Phase 2 study

Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer

A personalized ctDNA-based MRD test assesses residual disease and response in metastatic CRC to inform leronlimab development. More...
08 Jun 2026
By integrating CLC’s business, Diazyme aims to strengthen its clinical chemistry offering and broaden its diagnostic solutions for laboratories.

Diazyme Laboratories Acquires Carolina Liquid Chemistries

The acquisition brings together Diazyme’s proprietary enzyme and immunoassay technologies with CLC’s cost-effective chemistry systems and reagents. More...
03 Jun 2026
Image: Through the collaboration with SouthGenetics, healthcare professionals across Latin America and the Caribbean will gain access to C2N’s Precivity portfolio of blood tests

Partnership Expands Access to Alzheimer’s Blood Tests in Latin America and Caribbean

C2N Diagnostics and SouthGenetics have partnered to expand access to Precivity blood tests for Alzheimer’s disease assessment across Latin America and the Caribbean. More...
02 Jun 2026
Photo courtesy of Shutterstock

Global Multiplex Assays Market Driven by High-Throughput Diagnostic Demand

Market growth is driven by demand for high-throughput diagnostics, multi-biomarker analysis, and precision medicine. More...
01 Jun 2026
Image: Leica Biosystems and CellCarta have expanded a coordinated companion diagnostic (CDx) development model to biopharma sponsors worldwide

Global Framework Integrates Digital Pathology for Companion Diagnostic Development

Leica Biosystems and CellCarta have expanded a coordinated CDx development model to biopharma sponsors worldwide. More...
01 Jun 2026
Image: NHS-Galleri Trial: Percent difference in Stage IV cancers (Photo courtesy of GRAIL)

GRAIL Presents Full Results from NHS-Galleri Trial at ASCO 2026

GRAIL reported NHS-Galleri trial findings at ASCO 2026 showing fewer stage IV diagnoses despite missing the combined stage III–IV endpoint. More...
01 Jun 2026
Image: Together, the companies aim to streamline laboratory workflows and provide a fast, accurate “DNA-to-result” process using scalable nanopore sequencing

Werfen and Oxford Nanopore Collaborate on Transplant Assay Development

The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology. More...
28 May 2026
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Automated Coagulation Analyzer
Hemolumi H6


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.